1307 related articles for article (PubMed ID: 8615779)
41. Structural and genetic analysis of laminin-nidogen interaction.
Mayer U; Kohfeldt E; Timpl R
Ann N Y Acad Sci; 1998 Oct; 857():130-42. PubMed ID: 9917838
[TBL] [Abstract][Full Text] [Related]
42. Crystal Structure of the Heterotrimeric Integrin-Binding Region of Laminin-111.
Pulido D; Hussain SA; Hohenester E
Structure; 2017 Mar; 25(3):530-535. PubMed ID: 28132784
[TBL] [Abstract][Full Text] [Related]
43. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
44. Selective chain recognition in the C-terminal alpha-helical coiled-coil region of laminin.
Kammerer RA; Antonsson P; Schulthess T; Fauser C; Engel J
J Mol Biol; 1995 Jun; 250(1):64-73. PubMed ID: 7602597
[TBL] [Abstract][Full Text] [Related]
45. Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site.
Engvall E; Davis GE; Dickerson K; Ruoslahti E; Varon S; Manthorpe M
J Cell Biol; 1986 Dec; 103(6 Pt 1):2457-65. PubMed ID: 2430984
[TBL] [Abstract][Full Text] [Related]
46. Screening of integrin-binding peptides in a laminin peptide library derived from the mouse laminin β chain short arm regions.
Katagiri F; Takagi M; Nakamura M; Tanaka Y; Hozumi K; Kikkawa Y; Nomizu M
Arch Biochem Biophys; 2014 May; 550-551():33-41. PubMed ID: 24785228
[TBL] [Abstract][Full Text] [Related]
47. Identification of neurite outgrowth active sites on the laminin alpha4 chain G domain.
Ichikawa N; Kasai S; Suzuki N; Nishi N; Oishi S; Fujii N; Kadoya Y; Hatori K; Mizuno Y; Nomizu M; Arikawa-Hirasawa E
Biochemistry; 2005 Apr; 44(15):5755-62. PubMed ID: 15823034
[TBL] [Abstract][Full Text] [Related]
48. Crystallographic analysis of the laminin β2 short arm reveals how the LF domain is inserted into a regular array of LE domains.
Pulido D; Briggs DC; Hua J; Hohenester E
Matrix Biol; 2017 Jan; 57-58():204-212. PubMed ID: 27425256
[TBL] [Abstract][Full Text] [Related]
49. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.
Talts JF; Andac Z; Göhring W; Brancaccio A; Timpl R
EMBO J; 1999 Feb; 18(4):863-70. PubMed ID: 10022829
[TBL] [Abstract][Full Text] [Related]
50. Identification of laminin α5 short arm peptides active for endothelial cell attachment and tube formation.
Kikkawa Y; Sugawara Y; Harashima N; Fujii S; Ikari K; Kumai J; Katagiri F; Hozumi K; Nomizu M
J Pept Sci; 2017 Jul; 23(7-8):666-673. PubMed ID: 28220599
[TBL] [Abstract][Full Text] [Related]
51. Localization of heparin binding activity in recombinant laminin G domain.
Sung U; O'Rear JJ; Yurchenco PD
Eur J Biochem; 1997 Nov; 250(1):138-43. PubMed ID: 9432001
[TBL] [Abstract][Full Text] [Related]
52. Analysis of heparin, alpha-dystroglycan and sulfatide binding to the G domain of the laminin alpha1 chain by site-directed mutagenesis.
Andac Z; Sasaki T; Mann K; Brancaccio A; Deutzmann R; Timpl R
J Mol Biol; 1999 Mar; 287(2):253-64. PubMed ID: 10080889
[TBL] [Abstract][Full Text] [Related]
53. Characterization of a 21 amino acid peptide sequence of the laminin G2 domain that is involved in HNK-1 carbohydrate binding and cell adhesion.
Hall H; Vorherr T; Schachner M
Glycobiology; 1995 Jun; 5(4):435-41. PubMed ID: 7579798
[TBL] [Abstract][Full Text] [Related]
54. Structural analysis and proteolytic processing of recombinant G domain of mouse laminin alpha2 chain.
Talts JF; Mann K; Yamada Y; Timpl R
FEBS Lett; 1998 Apr; 426(1):71-6. PubMed ID: 9598981
[TBL] [Abstract][Full Text] [Related]
55. Heparin binding of laminin: contribution of the triple helix in the rod domain to the formation of cryptic and active sites in the globular domain.
Sung U
Mol Cells; 1997 Apr; 7(2):272-7. PubMed ID: 9163744
[TBL] [Abstract][Full Text] [Related]
56. Laminin-binding integrin alpha 7 beta 1: functional characterization and expression in normal and malignant melanocytes.
Kramer RH; Vu MP; Cheng YF; Ramos DM; Timpl R; Waleh N
Cell Regul; 1991 Oct; 2(10):805-17. PubMed ID: 1839357
[TBL] [Abstract][Full Text] [Related]
57. Binding of mouse and human fibulin-2 to extracellular matrix ligands.
Sasaki T; Göhring W; Pan TC; Chu ML; Timpl R
J Mol Biol; 1995 Dec; 254(5):892-9. PubMed ID: 7500359
[TBL] [Abstract][Full Text] [Related]
58. 12-O-tetradecanoylphorbol 13-acetate stimulates human T-lymphocyte adherence to the fibronectin RGD domain and the laminin IKVAV domain.
Weeks BS; Holloway E; Klotman PE; Akiyama SK; Schnaper HW; Kleinman HK
Cell Immunol; 1994 Jan; 153(1):94-104. PubMed ID: 8287495
[TBL] [Abstract][Full Text] [Related]
59. Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence.
Chakravarti S; Horchar T; Jefferson B; Laurie GW; Hassell JR
J Biol Chem; 1995 Jan; 270(1):404-9. PubMed ID: 7814401
[TBL] [Abstract][Full Text] [Related]
60. Human laminin: cloning and sequence analysis of cDNAs encoding A, B1 and B2 chains, and expression of the corresponding genes in human skin and cultured cells.
Olsen D; Nagayoshi T; Fazio M; Peltonen J; Jaakkola S; Sanborn D; Sasaki T; Kuivaniemi H; Chu ML; Deutzmann R
Lab Invest; 1989 Jun; 60(6):772-82. PubMed ID: 2733383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
